Neuronetics (STIM) Net Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.51% |
| Dec 31, 2025 | 16.47% |
| Sep 30, 2025 | 4.99% |
| Jun 30, 2025 | 21.13% |
| Mar 31, 2025 | 3.89% |
| Dec 31, 2024 | -41.82% |
| Sep 30, 2024 | 11.03% |
| Jun 30, 2024 | -20.73% |
| Mar 31, 2024 | -38.49% |
| Dec 31, 2023 | 37.63% |
| Sep 30, 2023 | -18.39% |
| Jun 30, 2023 | 22.84% |
| Mar 31, 2023 | -24.70% |
| Dec 31, 2022 | -5.66% |
| Sep 30, 2022 | 21.16% |
| Jun 30, 2022 | 4.65% |
| Mar 31, 2022 | -39.38% |
| Dec 31, 2021 | 2.47% |
| Sep 30, 2021 | -8.41% |
| Jun 30, 2021 | 4.47% |
| Mar 31, 2021 | -115.04% |
| Dec 31, 2020 | -7.15% |
| Sep 30, 2020 | 56.33% |
| Jun 30, 2020 | 33.32% |
| Mar 31, 2020 | -50.00% |
| Dec 31, 2019 | -8.07% |
| Sep 30, 2019 | 3.71% |
| Jun 30, 2019 | 5.48% |
| Mar 31, 2019 | -20.83% |
| Dec 31, 2018 | -25.48% |
| Sep 30, 2018 | 14.28% |
| Jun 30, 2018 | -11.04% |
| Mar 31, 2018 | -11.12% |
| Dec 31, 2017 | -37.49% |
| Sep 30, 2017 | -10.01% |
| Jun 30, 2017 | 27.55% |